126 related articles for article (PubMed ID: 32858102)
1. ARID1A-dependent permissive chromatin accessibility licenses estrogen-receptor signaling to regulate circadian rhythms genes in endometrial cancer.
Hu H; Chen Z; Ji L; Wang Y; Yang M; Lai R; Zhong Y; Zhang X; Wang L
Cancer Lett; 2020 Nov; 492():162-173. PubMed ID: 32858102
[TBL] [Abstract][Full Text] [Related]
2. Alternatively Constructed Estrogen Receptor Alpha-Driven Super-Enhancers Result in Similar Gene Expression in Breast and Endometrial Cell Lines.
Bojcsuk D; Nagy G; Bálint BL
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120995
[TBL] [Abstract][Full Text] [Related]
3. ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer.
Xu G; Chhangawala S; Cocco E; Razavi P; Cai Y; Otto JE; Ferrando L; Selenica P; Ladewig E; Chan C; Da Cruz Paula A; Witkin M; Cheng Y; Park J; Serna-Tamayo C; Zhao H; Wu F; Sallaku M; Qu X; Zhao A; Collings CK; D'Avino AR; Jhaveri K; Koche R; Levine RL; Reis-Filho JS; Kadoch C; Scaltriti M; Leslie CS; Baselga J; Toska E
Nat Genet; 2020 Feb; 52(2):198-207. PubMed ID: 31932695
[TBL] [Abstract][Full Text] [Related]
4. ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells.
Rodriguez AC; Vahrenkamp JM; Berrett KC; Clark KA; Guillen KP; Scherer SD; Yang CH; Welm BE; Janát-Amsbury MM; Graves BJ; Gertz J
Cancer Res; 2020 Mar; 80(6):1234-1245. PubMed ID: 32046982
[TBL] [Abstract][Full Text] [Related]
5. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
[TBL] [Abstract][Full Text] [Related]
6. MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions.
Mishra SK; Mazumdar A; Vadlamudi RK; Li F; Wang RA; Yu W; Jordan VC; Santen RJ; Kumar R
J Biol Chem; 2003 May; 278(21):19209-19. PubMed ID: 12639951
[TBL] [Abstract][Full Text] [Related]
7. ARID1A Mutations Promote P300-Dependent Endometrial Invasion through Super-Enhancer Hyperacetylation.
Wilson MR; Reske JJ; Holladay J; Neupane S; Ngo J; Cuthrell N; Wegener M; Rhodes M; Adams M; Sheridan R; Hostetter G; Alotaibi FT; Yong PJ; Anglesio MS; Lessey BA; Leach RE; Teixeira JM; Missmer SA; Fazleabas AT; Chandler RL
Cell Rep; 2020 Nov; 33(6):108366. PubMed ID: 33176148
[TBL] [Abstract][Full Text] [Related]
8. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
[TBL] [Abstract][Full Text] [Related]
9. The Role of ARID1A in Endometrial Cancer and the Molecular Pathways Associated With Pathogenesis and Cancer Progression.
Toumpeki C; Liberis A; Tsirkas I; Tsirka T; Kalagasidou S; Inagamova L; Anthoulaki X; Tsatsaris G; Kontomanolis EN
In Vivo; 2019; 33(3):659-667. PubMed ID: 31028182
[TBL] [Abstract][Full Text] [Related]
10. Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.
Kelso TWR; Porter DK; Amaral ML; Shokhirev MN; Benner C; Hargreaves DC
Elife; 2017 Oct; 6():. PubMed ID: 28967863
[TBL] [Abstract][Full Text] [Related]
11. Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions.
Rodriguez AC; Blanchard Z; Maurer KA; Gertz J
Horm Cancer; 2019 Jun; 10(2-3):51-63. PubMed ID: 30712080
[TBL] [Abstract][Full Text] [Related]
12. ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.
Wilson MR; Reske JJ; Holladay J; Wilber GE; Rhodes M; Koeman J; Adams M; Johnson B; Su RW; Joshi NR; Patterson AL; Shen H; Leach RE; Teixeira JM; Fazleabas AT; Chandler RL
Nat Commun; 2019 Aug; 10(1):3554. PubMed ID: 31391455
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association.
Tonsing-Carter E; Hernandez KM; Kim CR; Harkless RV; Oh A; Bowie KR; West-Szymanski DC; Betancourt-Ponce MA; Green BD; Lastra RR; Fleming GF; Chandarlapaty S; Conzen SD
Breast Cancer Res; 2019 Jul; 21(1):82. PubMed ID: 31340854
[TBL] [Abstract][Full Text] [Related]
14. The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2.
Helzer KT; Szatkowski Ozers M; Meyer MB; Benkusky NA; Solodin N; Reese RM; Warren CL; Pike JW; Alarid ET
Mol Cell Biol; 2019 Feb; 39(3):. PubMed ID: 30455249
[TBL] [Abstract][Full Text] [Related]
15. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
[TBL] [Abstract][Full Text] [Related]
16. A Homeostatic Arid1a-Dependent Permissive Chromatin State Licenses Hepatocyte Responsiveness to Liver-Injury-Associated YAP Signaling.
Li W; Yang L; He Q; Hu C; Zhu L; Ma X; Ma X; Bao S; Li L; Chen Y; Deng X; Zhang X; Cen J; Zhang L; Wang Z; Xie WF; Li H; Li Y; Hui L
Cell Stem Cell; 2019 Jul; 25(1):54-68.e5. PubMed ID: 31271748
[TBL] [Abstract][Full Text] [Related]
17. The emerging roles of ARID1A in tumor suppression.
Wu RC; Wang TL; Shih IeM
Cancer Biol Ther; 2014 Jun; 15(6):655-64. PubMed ID: 24618703
[TBL] [Abstract][Full Text] [Related]
18. An estrogen receptor alpha-dependent regulation of estrogen receptor-related receptor alpha in the proliferation of endometrial carcinoma cells.
Sun PM; Gao M; Wei LH; Mustea A; Wang JL; Könsgen D; Lichtenegger W; Sehouli J
Int J Gynecol Cancer; 2006; 16 Suppl 2():564-8. PubMed ID: 17010074
[TBL] [Abstract][Full Text] [Related]
19. Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells.
Hu P; Kinyamu HK; Wang L; Martin J; Archer TK; Teng C
J Biol Chem; 2008 Mar; 283(11):6752-63. PubMed ID: 18174157
[TBL] [Abstract][Full Text] [Related]
20. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]